199 related articles for article (PubMed ID: 25696994)
1. [Aberrant expression of sox2 gene in malignant gliomas].
Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
[TBL] [Abstract][Full Text] [Related]
2. THE ANALYSIS OF LGI1 GENE EPIGENETIC ALTERATIONS BY MEANS OF POSTTRANSLATIONAL H3 HISTONE MODIFICATIONS IN MALIGNANT GLIOMAS.
Semenova EV; Volnitsky AV; Filatov MV
Tsitologiia; 2016; 58(5):335-9. PubMed ID: 30188624
[TBL] [Abstract][Full Text] [Related]
3. [Genetic and epigenetic markers of gliomas].
Semenova EV; Filatov MV
Tsitologiia; 2013; 55(5):290-9. PubMed ID: 24592735
[TBL] [Abstract][Full Text] [Related]
4. SOX2 expression and amplification in gliomas and glioma cell lines.
Annovazzi L; Mellai M; Caldera V; Valente G; Schiffer D
Cancer Genomics Proteomics; 2011; 8(3):139-47. PubMed ID: 21518820
[TBL] [Abstract][Full Text] [Related]
5. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
[TBL] [Abstract][Full Text] [Related]
7. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
8. Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells.
Ferletta M; Caglayan D; Mokvist L; Jiang Y; Kastemar M; Uhrbom L; Westermark B
Int J Cancer; 2011 Jul; 129(1):45-60. PubMed ID: 20824710
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling.
Luo G; Luo W; Sun X; Lin J; Wang M; Zhang Y; Luo W; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):187-193. PubMed ID: 27909726
[TBL] [Abstract][Full Text] [Related]
10. [The significance of histone modifications in malignant transformation].
Gomulak P; Błasiak J
Postepy Biochem; 2012; 58(3):292-301. PubMed ID: 23373415
[TBL] [Abstract][Full Text] [Related]
11. Mutations in chromatin machinery and pediatric high-grade glioma.
Lulla RR; Saratsis AM; Hashizume R
Sci Adv; 2016 Mar; 2(3):e1501354. PubMed ID: 27034984
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics in human gliomas.
Kreth S; Thon N; Kreth FW
Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
[TBL] [Abstract][Full Text] [Related]
13. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
15. "Smad"eningly erratic: target gene methylation determines whether TGFbeta promotes or suppresses malignant glioma.
Kesari S; Jackson-Grusby L; Stiles CD
Dev Cell; 2007 Mar; 12(3):324-5. PubMed ID: 17336898
[TBL] [Abstract][Full Text] [Related]
16. Histone onco-modifications.
Füllgrabe J; Kavanagh E; Joseph B
Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
[TBL] [Abstract][Full Text] [Related]
17. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.
J Dabrowski M; Wojtas B
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166
[TBL] [Abstract][Full Text] [Related]
18. Notch inhibition via micro-RNA blocks glioma development.
Berry N; Gursel DB; Boockvar JA
Neurosurgery; 2012 Apr; 70(4):N20-2. PubMed ID: 22426058
[No Abstract] [Full Text] [Related]
19. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
[TBL] [Abstract][Full Text] [Related]
20. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
